These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11832343)

  • 1. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC; Lidington EA; Ahmad SR; Haskard DO
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Lidington EA; Haskard DO; Mason JC
    Blood; 2000 Oct; 96(8):2784-92. PubMed ID: 11023512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
    Hata Y; Rook SL; Aiello LP
    Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A.
    Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO
    J Biol Chem; 2004 Oct; 279(40):41611-8. PubMed ID: 15284224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
    Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.
    Bernatchez PN; Allen BG; Gélinas DS; Guillemette G; Sirois MG
    Br J Pharmacol; 2001 Nov; 134(6):1253-62. PubMed ID: 11704645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
    Tokuda H; Kozawa O; Uematsu T
    J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
    Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.
    D'Angelo G; Lee H; Weiner RI
    J Cell Biochem; 1997 Dec; 67(3):353-66. PubMed ID: 9361190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity.
    Shizukuda Y; Tang S; Yokota R; Ware JA
    Circ Res; 1999 Aug; 85(3):247-56. PubMed ID: 10436167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
    Mandriota SJ; Pepper MS
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis.
    Kinderlerer AR; Steinberg R; Johns M; Harten SK; Lidington EA; Haskard DO; Maxwell PH; Mason JC
    Arthritis Res Ther; 2006; 8(4):R130. PubMed ID: 16859540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.
    Pepper MS; Ferrara N; Orci L; Montesano R
    Biochem Biophys Res Commun; 1992 Dec; 189(2):824-31. PubMed ID: 1281999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.